Aptamers Market Research Report Information By Type (Nucleic Acid Aptamer and Peptide Aptamer), By Application (Diagnosis, Therapeutics, Research & Development, and Others), And By Region (North America, Europe, Asia-Pacific, And The Rest Of The World) –Market Forecast Till 2032

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Aptamers Market, by Type

6.1 Introduction

6.2 Nucleic acid aptamers

6.2.1 DNA-Based Aptamers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2 RNA-Based Aptamers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3 Peptide aptamers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 7. Global Aptamers Market, by Application

7.1 Introduction

7.2 Diagnostics

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3 Therapeutics development

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.4 Research and development

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.5 Other applications

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 8. Global Aptamers Market, by Technology

8.1 Introduction

8.2 Selex

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.3 X-aptamer

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.4 MARAS technique

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 9. Global Aptamers Market, by End-Users

9.1 Introduction

9.2 Academic and government research institutes

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.3 Biotechnology and pharmaceutical companies

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.4 Contract research organizations

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.5 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 10. Global Aptamers Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America:

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Aptamer Sciences, Inc.

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Aptagen, LLC

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

10.2.5 SWOT Analysis

12.3 Base Pair Biotechnologies, Inc.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Ophthotech Corporation

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Am Biotechnologies, LLC

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Aptamer Solutions Ltd.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Aptus Biotech S.L.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Neoventures Biotechnology Inc.

12.8.1 Overview

12.8.2 Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Somalogic, Inc.

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Trilink Biotechnologies, Inc.

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Vivonics, Inc.

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Noxxon Pharma

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

12.13.1 Overview

12.13.2 Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Aptamers Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Aptamers Market Synopsis, 2023-2032

Table 2 Global Aptamers Market Estimates and Forecast, 2023-2032 (USD Million)

Table 3 Global Aptamers Market, by Region, 2023-2032 (USD Million)

Table 4 Global Aptamers Market, by Type, 2023-2032 (USD Million)

Table 5 Global Aptamers Market, by Application, 2023-2032 (USD Million)

Table 6 Global Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 7 Global Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 8 North America: Aptamers Market, by Type, 2023-2032 (USD

Million)

Table 9 North America: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 10 North America: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 11 North America: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 12 US: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 13 US: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 14 US: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 15 US: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 16 Canada: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 17 Canada: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 18 Canada: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 19 Canada: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 20 South America: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 21 South America: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 22 South America: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 23 South America: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 24 Europe: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 25 Europe: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 26 Europe: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 27 Europe: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 28 Western Europe: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 29 Western Europe: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 30 Western Europe: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 31 Western Europe: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 32 Eastern Europe: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 33 Eastern Europe: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 34 Eastern Europe: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 35 Eastern Europe: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 36 Asia-Pacific: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 37 Asia-Pacific: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 38 Asia-Pacific: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 39 Asia-Pacific: Aptamers Market, by End-users, 2023-2032 (USD Million)

Table 40 Middle East & Africa: Aptamers Market, by Type, 2023-2032 (USD Million)

Table 41 Middle East & Africa: Aptamers Market, by Application, 2023-2032 (USD Million)

Table 42 Middle East & Africa: Aptamers Market, by Technology, 2023-2032 (USD Million)

Table 43 Middle East & Africa: Aptamers Market, by End-users, 2023-2032 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Aptamers Market

Figure 3 Segmentation Market Dynamics for Global Aptamers Market

Figure 4 Global Aptamers Market Share, by Type, 2020

Figure 5 Global Aptamers Market, by End-users, 2020–2027 (USD Million)

Figure 6 Global Aptamers Market Share, by Region, 2020

Figure 7 North America: Aptamers Market Share, by Country, 2020

Figure 8 Europe: Aptamers Market Share, by Country, 2020

Figure 9 Asia-Pacific: Aptamers Market Share, by Country, 2020

Figure 10 Middle East & Africa: Aptamers Market Share, by Country, 2020

Figure 11 Global Aptamers Market: Company Share Analysis, 2020 (%)

Figure 12 Aptamer Sciences, Inc.: Key Financials

Figure 13 Aptamer Sciences, Inc.: Segmental Revenue

Figure 14 Aptamer Sciences, Inc.: Geographical Revenue

Figure 15 Aptagen, LLC: Key Financials

Figure 16 Aptagen, LLC: Segmental Revenue

Figure 17 Aptagen, LLC: Geographical Revenue

Figure 18 Base Pair Biotechnologies, Inc.: Key Financials

Figure 19 Base Pair Biotechnologies, Inc.: Segmental Revenue

Figure 20 Base Pair Biotechnologies, Inc.: Geographical Revenue

Figure 21 Ophthotech Corporation: Key Financials

Figure 22 Ophthotech Corporation: Segmental Revenue

Figure 23 Ophthotech Corporation: Geographical Revenue

Figure 24 Am Biotechnologies, LLC: Key Financials

Figure 25 Am Biotechnologies, LLC: Segmental Revenue

Figure 26 Am Biotechnologies, LLC: Geographical Revenue

Figure 27 Aptamer Solutions Ltd: Key Financials

Figure 28 Aptamer Solutions Ltd: Segmental Revenue

Figure 29 Aptamer Solutions Ltd: Geographical Revenue

Figure 30 Aptus Biotech S.L.: Key Financials

Figure 31 Aptus Biotech S.L.: Segmental Revenue

Figure 32 Aptus Biotech S.L.: Geographical Revenue

Figure 33 Neoventures Biotechnology Inc.: Key Financials

Figure 34 Neoventures Biotechnology Inc.: Segmental Revenue

Figure 35 Neoventures Biotechnology Inc.: Geographical Revenue

Figure 36 Somalogic, Inc.: Key Financials

Figure 37 Somalogic, Inc.: Segmental Revenue

Figure 38 Somalogic, Inc.: Geographical Revenue

Figure 39 Trilink Biotechnologies, Inc.: Key Financials

Figure 40 Trilink Biotechnologies, Inc.: Segmental Revenue

Figure 41 Trilink Biotechnologies, Inc.: Geographical Revenue

Figure 42 Vivonics, Inc.: Key Financials

Figure 43 Vivonics, Inc.: Segmental Revenue

Figure 44 Vivonics, Inc.: Geographical Revenue

Figure 45 Noxxon Pharma: Key Financials

Figure 46 Noxxon Pharma: Segmental Revenue

Figure 47 Noxxon Pharma: Geographical Revenue

Figure 48 Others: Key Financials

Figure 49 Others: Segmental Revenue

Figure 50 Others: Geographical Revenue